ReviewCancer metastasis reviews2025
Recent advances and treatment strategies in liver metastasis of pancreatic neuroendocrine tumors.
Review in Cancer metastasis reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Therapeutic potential and mechanisms of rehabilitation interventions in preventing cancer metastasis.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Pancreatic neuroendocrine tumors (pNETs) are characterized by significant spatial and temporal heterogeneity, exhibiting a wide spectrum of biological behaviors, histopathological features, and clinical presentations. The presence of liver metastases in pNETs is a critical prognostic factor that markedly alters the natural history of the disease and therapeutic outlook. Hepatic metastasis significantly influences treatment strategies, necessitating a multidisciplinary team (MDT) approach that integrates expertise from surgery, pathology, medical oncology, interventional radiology, and radiation oncology. Advances have been made in surgical resection, pharmacotherapy, interventional treatments, and radiotherapy. Evidence-based treatment paradigms tailored to different tumor grades and stages have been recommended by multiple specialty guidelines. This review summarizes recent progress in the field, covering topics such as the mechanisms underlying liver metastasis, advances in clinical research, controversies in surgical management, the role of neoadjuvant therapy prior to surgery, and options for non-surgical treatment modalities. It emphasizes the importance of regular MDT meetings to refine individualized treatment plans and to promptly address emerging challenges-such as treatment resistance and disease progression-with the ultimate goal of improving patient outcomes and quality of life.
Indexed as
Identifiers
41318734What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.